Hoang Duc and multinational pharmaceutical corporations operating in Vietnam provide patient support programs (PAP/PSP) in compliance with the provisions of Circular No. 31/2018/TT-BYT.
Hoang Duc and its partners select the best products to support Vietnamese patients through the approval of the Ministry of Health for each PAP/PSP program. PAP/PSP programs help Vietnamese patients:
- Reduce treatment costs
- Increase access to new drugs
- Improve optimal treatment outcomes
- Improve quality of life